Business Wire

Cinemo to elevate in-car entertainment with personal smart devices in Mahindra’s new electric origin SUV range

12.6.2025 08:27:00 CEST | Business Wire | Press Release

Share

Cinemo, a global leader in high-performance and automotive-grade multimedia playback, streaming, media management, connectivity, and cloud middleware, is pleased to announce that India’s leading SUV manufacturer Mahindra has chosen Cinemo as its infotainment solutions technology provider. Cinemo is set to power bring-your-own-device (BYOD) infotainment capabilities for Mahindra’s range of electric origin SUVs (eSUVs), delivering exceptional infotainment experiences with personal devices.

With the launch of their two new eSUV models, Mahindra is raising the bar for in-car entertainment. For their modular INGLO platform and intelligence suite (Mahindra Artificial Intelligence Architecture – MAIA), Mahindra selected Cinemo's CARS Connect Suite to enable premium digital media experiences on brought-in devices. The project advanced from kick-off to production in an impressive six months, showcasing Mahindra's efficiency and commitment while upholding high-quality standards and leveraging advanced Android pre-integration capabilities.

Cinemo CARS Connect creates a unified and connected in-car ecosystem that seamlessly integrates content sharing, intuitive control for all passengers, and interaction across multiple screens and devices. It allows passengers to manage media playback, share audio and video content, and control vehicle functions directly from their own devices, providing a personalized yet inclusive experience that minimizes driver distraction. Passengers also benefit from multi-zone audio, which delivers distinct audio experiences, allowing everyone to enjoy their preferred content without interference. By having full control over their preferred content, car users will be able to create individual and memorable in-car digital media moments.

Cinemo CARS™ once again proves its ability to enrich, enhance, and accelerate implementation of AAOS-based infotainment systems. This allows Mahindra to add innovative entertainment use cases within a short time to market to its eSUV models, covering the rapidly growing car markets in India and Southeast Asia.

“We are delighted to bring our renowned digital media experiences to India’s leading SUV manufacturer,” says Abe Silhan, Director Portfolio Management at Cinemo. “We are continuing our pursuit of groundbreaking innovation in in-car infotainment and are proud of our contribution to Mahindra’s advanced lineup of Electric SUVs.”

About Cinemo

Cinemo is a global provider of highly innovative infotainment products that make every screen an opportunity. Its range of award-winning, fully integrated, low-footprint digital media offerings combine high performance with high quality and are truly system agnostic.

Whether embedded, as mobile apps or through the cloud, Cinemo supports all digital media scenarios for any industry and any device. Its product portfolio is designed and built to deliver excellence, accelerate time to market, and lower TCO for its clients while creating digital media experiences that matter.

Founded in 2008, and with a strong history of industry firsts, Cinemo is the partner of choice for more than 40 market-leading OEMs and over 20 tier-1s. The company works with the top high-tech and consumer electronic companies as well as global music and video content providers. Cinemo’s global team of 300+ innovative thinkers from 40 nationalities continuously delivers groundbreaking innovation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250611615322/en/

Contacts

Press contacts
Cinemo | Martina Oerther, Marketing Director (moerther@cinemo.com)

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye